| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comprehensive review of lenalidomide in B-cell non-Hodgkin lymphoma
|
Arora, Mili
|
|
2016
|
|
4 |
p. 209-221
|
artikel
|
| 2 |
Bortezomib for the treatment of mantle cell lymphoma: an update
|
Hambley, Bryan
|
|
2016
|
|
4 |
p. 196-208
|
artikel
|
| 3 |
Bruton’s tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinib
|
Aalipour, Amin
|
|
2014
|
|
4 |
p. 121-133
|
artikel
|
| 4 |
Co-expression of MYC and BCL2 predicts poorer outcomes for relapsed/refractory diffuse large B-cell lymphoma with R-ICE and intent to transplant
|
Allen, Joshua
|
|
2018
|
|
4 |
p. 81-87
|
artikel
|
| 5 |
Editorial
|
Mauro, Michael J.
|
|
2011
|
|
4 |
p. 201-201
|
artikel
|
| 6 |
Editorial
|
Mauro, Michael J.
|
|
2012
|
|
4 |
p. 197-198
|
artikel
|
| 7 |
Editorial
|
Gotlib, Jason
|
|
2013
|
|
4 |
p. 235-236
|
artikel
|
| 8 |
Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment
|
Magen, Hila
|
|
2016
|
|
4 |
p. 187-195
|
artikel
|
| 9 |
Experience with ruxolitinib in the treatment of polycythaemia vera
|
Alimam, Samah
|
|
2017
|
|
4 |
p. 139-151
|
artikel
|
| 10 |
Experimental approaches in the treatment of multiple myeloma
|
Khan, Saad A.
|
|
2011
|
|
4 |
p. 213-230
|
artikel
|
| 11 |
Genetic predispositions to childhood leukemia
|
Stieglitz, Elliot
|
|
2013
|
|
4 |
p. 270-290
|
artikel
|
| 12 |
Ibrutinib in Waldenström macroglobulinemia: latest evidence and clinical experience
|
Castillo, Jorge J.
|
|
2016
|
|
4 |
p. 179-186
|
artikel
|
| 13 |
Inherited predisposition to multiple myeloma
|
Koura, Divya T.
|
|
2013
|
|
4 |
p. 291-297
|
artikel
|
| 14 |
Inherited predisposition to myeloproliferative neoplasms
|
Jones, Amy V.
|
|
2013
|
|
4 |
p. 237-253
|
artikel
|
| 15 |
Inherited susceptibility to chronic lymphocytic leukemia: evidence and prospects for the future
|
Brown, Jennifer R.
|
|
2013
|
|
4 |
p. 298-308
|
artikel
|
| 16 |
Invasive fungal infections in acute leukemia
|
Bhatt, Vijaya R.
|
|
2011
|
|
4 |
p. 231-247
|
artikel
|
| 17 |
JAK inhibitors and other novel agents in myeloproliferative neoplasms: are we hitting the target?
|
Kucine, Nicole
|
|
2011
|
|
4 |
p. 203-211
|
artikel
|
| 18 |
Novel targeted treatment strategies for refractory chronic lymphocytic leukaemia
|
Schnaiter, Andrea
|
|
2011
|
|
4 |
p. 249-265
|
artikel
|
| 19 |
Ofatumumab plus chlorambucil as a first-line therapy in less fit patients with chronic lymphocytic leukemia: analysis of COMPLEMENT1 and other monoclonal antibodies association data
|
Frustaci, Anna Maria
|
|
2016
|
|
4 |
p. 222-230
|
artikel
|
| 20 |
Pembrolizumab and its role in relapsed/refractory classical Hodgkin’s lymphoma: evidence to date and clinical utility
|
Shindiapina, Polina
|
|
2018
|
|
4 |
p. 89-105
|
artikel
|
| 21 |
Point-of-care ultrasonography (POCUS) in hemophilia A: a commentary on current status and its potential role for improving prophylaxis management in severe hemophilia A
|
Acharya, Suchitra S.
|
|
2017
|
|
4 |
p. 153-156
|
artikel
|
| 22 |
Practical management of patients with chronic myeloid leukemia who develop tyrosine kinase inhibitor-resistant BCR-ABL1 mutations
|
Ai, Jing
|
|
2014
|
|
4 |
p. 107-120
|
artikel
|
| 23 |
Priming radioimmunotherapy with external beam radiation in patients with relapsed low grade non-Hodgkin lymphoma
|
Abuodeh, Yazan
|
|
2017
|
|
4 |
p. 129-138
|
artikel
|
| 24 |
Recent advances in the diagnosis and treatment of heparin-induced thrombocytopenia
|
Bakchoul, Tamam
|
|
2012
|
|
4 |
p. 237-251
|
artikel
|
| 25 |
Recognizing familial myeloid leukemia in adults
|
Nickels, Eric M.
|
|
2013
|
|
4 |
p. 254-269
|
artikel
|
| 26 |
Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphoma
|
Vaklavas, Christos
|
|
2012
|
|
4 |
p. 209-225
|
artikel
|
| 27 |
Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease
|
Richardson, Paul G.
|
|
2012
|
|
4 |
p. 253-265
|
artikel
|
| 28 |
Safety and efficacy of ofatumumab in patients with fludarabine and alemtuzumab refractory chronic lymphocytic leukaemia
|
Dyer, Martin J.S.
|
|
2012
|
|
4 |
p. 199-207
|
artikel
|
| 29 |
Safety and efficacy of pralatrexate in the treatment of patients with relapsed or refractory peripheral T-cell lymphoma
|
Marchi, Enrica
|
|
2012
|
|
4 |
p. 227-235
|
artikel
|
| 30 |
The bone marrow microenvironment in Waldenstrom macroglobulinemia
|
Ghobrial, Irene M.
|
|
2011
|
|
4 |
p. 267-272
|
artikel
|
| 31 |
Unusual, spontaneous aneurysm formation in a patient being treated with ibrutinib for chronic lymphocytic leukemia
|
Wiedower, Eric
|
|
2016
|
|
4 |
p. 231-232
|
artikel
|
Tijdschrift beschrijving